Skip to main content
. 2023 Mar 23;15(4):1043. doi: 10.3390/pharmaceutics15041043

Figure 5.

Figure 5

Overlaid XRD pattern: (A) lyophilized nicotine–stearic acid loaded SLNs, (B) nicotine–stearic acid conjugate, (C) Compritol 888 ATO, (D) blank SLNs, and (E) Poloxamer 188.